These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 8916880)

  • 21. Interleukin-6: biologic properties and role in lymphoproliferative disorders.
    Seymour JF; Kurzrock R
    Cancer Treat Res; 1996; 84():167-206. PubMed ID: 8724631
    [No Abstract]   [Full Text] [Related]  

  • 22. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma.
    Maier B; Lefering R; Lehnert M; Laurer HL; Steudel WI; Neugebauer EA; Marzi I
    Shock; 2007 Dec; 28(6):668-674. PubMed ID: 18092384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of soluble interleukin-6 receptor on interleukin-6 synthesis in human skin fibroblasts.
    Cichy J; Rose-John S; Pryjma J; Travis J
    Biochem Biophys Res Commun; 1996 Oct; 227(2):318-21. PubMed ID: 8878515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma.
    O'Nualláin EM; Puri P; Mealy K; Reen DJ
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage.
    Schneider CP; Schwacha MG; Chaudry IH
    Biochim Biophys Acta; 2004 May; 1689(1):22-32. PubMed ID: 15158910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early immunologic responses to trauma in the emergency department patients with major injuries.
    Yadav K; Zehtabchi S; Nemes PC; Miller AC; Azher M; Durkin H; Sinert R
    Resuscitation; 2009 Jan; 80(1):83-8. PubMed ID: 18995945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury.
    Walsh DS; Thavichaigarn P; Pattanapanyasat K; Siritongtaworn P; Kongcharoen P; Tongtawe P; Yongvanitchit K; Jiarakul N; Dheeradhada C; Pearce FJ; Wiesmann WP; Webster HK
    J Surg Res; 2005 Dec; 129(2):221-30. PubMed ID: 16045935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proinflammatory cytokine production by mitogen-stimulated peripheral blood mononuclear cells (PBMCs) in trauma patients fed immune-enhancing enteral diets.
    Jeevanandam M; Shahbazian LM; Petersen SR
    Nutrition; 1999; 15(11-12):842-7. PubMed ID: 10575658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The early second hit in trauma management augments the proinflammatory immune response to multiple injuries.
    Tschoeke SK; Hellmuth M; Hostmann A; Ertel W; Oberholzer A
    J Trauma; 2007 Jun; 62(6):1396-403; discussion 1403-4. PubMed ID: 17563655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The early IL-6 and IL-10 response in trauma is correlated with injury severity and mortality.
    Stensballe J; Christiansen M; Tønnesen E; Espersen K; Lippert FK; Rasmussen LS
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):515-21. PubMed ID: 19317866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the role of gammadelta T lymphocytes in the immunopathogenic response to thermal injury.
    Schwacha MG; Ayala A; Chaudry IH
    J Leukoc Biol; 2000 May; 67(5):644-50. PubMed ID: 10811004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-interleukin-6 antibody treatment restores cell-mediated immune function in mice with acute ethanol exposure before burn trauma.
    Fontanilla CV; Faunce DE; Gregory MS; Messingham KA; Durbin EA; Duffner LA; Kovacs EJ
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1392-9. PubMed ID: 11003205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro.
    Iglesias M; Plowman GD; Woodworth CD
    Am J Pathol; 1995 Apr; 146(4):944-52. PubMed ID: 7717461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-10 and Gp130 cytokines in human multiple myeloma.
    Klein B; Lu ZY; Gu ZJ; Costes V; Jourdan M; Rossi JF
    Leuk Lymphoma; 1999 Jun; 34(1-2):63-70. PubMed ID: 10350333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linking the "two-hit" response following injury to enhanced TLR4 reactivity.
    Murphy TJ; Paterson HM; Kriynovich S; Zang Y; Kurt-Jones EA; Mannick JA; Lederer JA
    J Leukoc Biol; 2005 Jan; 77(1):16-23. PubMed ID: 15496450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
    Franchimont N; Durant D; Canalis E
    Endocrinology; 1997 Aug; 138(8):3380-6. PubMed ID: 9231791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could Beta blockade improve outcome after injury by modulating inflammatory profiles?
    Friese RS; Barber R; McBride D; Bender J; Gentilello LM
    J Trauma; 2008 Apr; 64(4):1061-8. PubMed ID: 18404076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [gp-130 related cytokines in mechanisms of myeloma cell growth].
    Fukutoku M; Shimizu S
    Rinsho Ketsueki; 1997 Apr; 38(4):262-5. PubMed ID: 9146047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.